Duvortuxizumab
Duvortuxizumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Duvortuxizumab is under investigation in clinical trial NCT02743546 (Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma).
| Trade Name | Duvortuxizumab |
| Generic | Duvortuxizumab |
| Duvortuxizumab Other Names | Duvortuxizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Duvortuxizumab
